Omada Health, Inc. released FY2024 earnings on May 9, 2025 (EST) with actual revenue of USD 169.8 M and EPS of USD -6.1047
Brief Summary
Omada Health, Inc. reported a revenue of $170 million and an EPS of -$6.1047 for its fiscal year 2024 financial results.
Impact of The News
Financial Performance Analysis
Revenue: Omada Health, Inc. reported a revenue of $170 million for fiscal year 2024. This indicates a relatively stable performance in terms of revenue when compared to the broader industry or peers that have reported significant revenue growth.
Earnings Per Share (EPS): The company reported an EPS of -$6.1047, indicating a loss per share. This is a significant negative figure when compared to other companies, such as Stonex Group Inc., which reported a positive EPS of $1.63 per share GlobeNewswire.
Comparison with Peers
ARM Holdings: ARM reported a significant milestone with its revenue surpassing $3 billion for the first time in 2024, contrasting with Omada Health’s relatively lower revenue figures .
Advanced Micro Devices (AMD): In its 2024 Q3 report, AMD showed a substantial revenue of $3.85 billion with a year-over-year growth of 200%, which places Omada Health’s results in a weaker position in the industry .
Business Implications and Trends
Market Expectations: The negative EPS suggests that Omada Health may have missed market expectations, especially when compared to peers showing profit and growth. This could result in negative investor sentiment and potential stock price volatility.
Business Development Trends: With a net loss, Omada Health may need to reevaluate its business strategies to enhance revenue streams or reduce costs. Focus might be needed on operational efficiency or new market opportunities to improve financial health.
In conclusion, Omada Health’s financial results underline the need for strategic adjustments amid competitive industry performance and investor expectations.
